{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:55:30Z","timestamp":1794938130575,"version":"4.9.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T00:00:00Z","timestamp":1535414400000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1A1A02019106"],"award-info":[{"award-number":["2017R1D1A1A02019106"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2017R1D1A1A02019106"],"award-info":[{"award-number":["2017R1D1A1A02019106"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"published-print":{"date-parts":[[2018,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Protein arginine methylation is a novel form of posttranslational modification mediated by protein arginine methyltransferase (PRMTs). PRMT1, a major isoform of the PRMT family, is responsible for various biological functions, including cellular differentiation. Although the important function that PRMT1 plays in various tissues is being increasingly recognized, its role in receptor activation of NF-\u03baB ligand (RANKL)-induced osteoclastogenesis or osteoporosis has not yet been described. Here, we show that PRMT1 is essential for RANKL-induced osteoclastogenesis in vitro and for bone loss in vivo. RANKL treatment increased the expression of PRMT1 and its nuclear localization in bone marrow-derived macrophages (BMDMs) in a c-Jun N-terminal kinase (JNK)-dependent manner. Silencing PRMT1 attenuated RANKL-induced osteoclastogenesis by decreasing tartrate-resistant acid phosphatase (TRAP)-positive cells and inhibiting F-actin ring formation and bone resorption, which was confirmed in a separate experiment using haploinsufficient cells from\n                    <jats:italic>PRMT1<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>+\/-<\/jats:italic>\n                    <\/jats:sup>\n                    mice. Our results also revealed that PRMT1 regulates the transcription activity of NF-\u03baB by directly interacting with it in RANKL-treated BMDMs. An in vivo study showed that the haploinsufficiency of PRMT1 reduced the enzyme activity of TRAP and increased the bone mineral density in the metaphysis of ovariectomized (OVX) mice. Finally, treatment with estrogen (E2) downregulated the RANKL-induced expression of PRMT1, suggesting that estrogen may exert an inhibitory effect on osteoclastogenesis by suppressing PRMT1 expression. Our results suggest that PRMT1 plays an important role in the progression of osteoporosis and that it might be a good therapeutic target for postmenopausal osteoporosis.\n                  <\/jats:p>","DOI":"10.1038\/s12276-018-0134-x","type":"journal-article","created":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T01:12:14Z","timestamp":1535418734000},"page":"1-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["PRMT1 mediates RANKL-induced osteoclastogenesis and contributes to bone loss in ovariectomized mice"],"prefix":"10.1038","volume":"50","author":[{"given":"Joo-Hee","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ah-Ra","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Jung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seul-Ki","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Sun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,8,28]]},"reference":[{"key":"134_CR1","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/nature01654","volume":"423","author":"G Karsenty","year":"2003","unstructured":"Karsenty, G. The complexities of skeletal biology. Nature 423, 316\u2013318 (2003).","journal-title":"Nature"},{"key":"134_CR2","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.pbiomolbio.2016.05.008","volume":"122","author":"X Li","year":"2016","unstructured":"Li, X. et al. Disturbed MEK\/ERK signaling increases osteoclast activity via the Hedgehog-Gli pathway in postmenopausal osteoporosis. Pro. Biophys. Mol. Biol. 122, 101\u2013111 (2016).","journal-title":"Pro. Biophys. Mol. Biol."},{"key":"134_CR3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1098\/rsif.2009.0282","volume":"7","author":"LM McNamara","year":"2010","unstructured":"McNamara, L. M. Perspective on post-menopausal osteoporosis: establishing an interdisciplinary understanding of the sequence of events from the molecular level to whole bone fractures. J. R. Soc. Interface 7, 353\u2013372 (2010).","journal-title":"J. R. Soc. Interface"},{"key":"134_CR4","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1359\/jbmr.2005.20.5.886","volume":"20","author":"LJ Melton","year":"2005","unstructured":"Melton, L. J., Chrischilles, E. A., Cooper, C., Lane, A. W. & Riggs, B. L. How many women have osteoporosis? J. Bone Miner. Res. 20, 886\u2013892 (2005).","journal-title":"J. Bone Miner. Res."},{"key":"134_CR5","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1001\/jama.291.14.1701","volume":"291","author":"GL Anderson","year":"2004","unstructured":"Anderson, G. L. et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women\u2019s Health Initiative randomized controlled trial. J. Am. Med Assoc. 291, 1701\u20131712 (2004).","journal-title":"J. Am. Med Assoc."},{"key":"134_CR6","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.tcb.2004.09.016","volume":"14","author":"FJ Pixley","year":"2004","unstructured":"Pixley, F. J. & Stanley, E. R. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 14, 628\u2013638 (2004).","journal-title":"Trends Cell Biol."},{"key":"134_CR7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1172\/JCI36809","volume":"119","author":"H Kim","year":"2009","unstructured":"Kim, H. et al. Selective inhibition of RANK blocks osteoclast maturation and function and prevents bone loss in mice. J. Clin. Invest. 119, 813\u2013825 (2009).","journal-title":"J. Clin. Invest."},{"key":"134_CR8","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1038\/sj.cdd.4401882","volume":"13","author":"H Huang","year":"2006","unstructured":"Huang, H. et al. Osteoclast differentiation requires TAK1 and MKK6 for NFATc1 induction and NF-kappaB transactivation by RANKL. Cell Death Differ. 13, 1879\u20131891 (2006).","journal-title":"Cell Death Differ."},{"key":"134_CR9","doi-asserted-by":"crossref","first-page":"26475","DOI":"10.1074\/jbc.M313973200","volume":"279","author":"K Matsuo","year":"2004","unstructured":"Matsuo, K. et al. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-Fos. J. Biol. Chem. 279, 26475\u201326480 (2004).","journal-title":"J. Biol. Chem."},{"key":"134_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.10.033","volume":"513","author":"SH Yang","year":"2013","unstructured":"Yang, S.-H., Sharrocks, A. D. & Whitmarsh, A. J. MAP kinase signalling cascades and transcriptional regulation. Gene 513, 1\u201313 (2013).","journal-title":"Gene"},{"key":"134_CR11","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.exer.2009.09.004","volume":"89","author":"Y Chen","year":"2009","unstructured":"Chen, Y. et al. PRMT-1 and DDAHs-induced ADMA upregulation is involved in ROS- and RAS-mediated diabetic retinopathy. Exp. Eye Res. 89, 1028\u20131034 (2009).","journal-title":"Exp. Eye Res."},{"key":"134_CR12","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1074\/jbc.C700192200","volume":"283","author":"AN Iberg","year":"2008","unstructured":"Iberg, A. N. et al. Arginine methylation of the histone H3 tail impedes effector binding. J. Biol. Chem. 283, 3006\u20133010 (2008).","journal-title":"J. Biol. Chem."},{"key":"134_CR13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrc3409","volume":"13","author":"Y Yang","year":"2013","unstructured":"Yang, Y. & Bedford, M. T. Protein arginine methyltransferases and cancer. Nat. Rev. Cancer 13, 37\u201350 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"134_CR14","doi-asserted-by":"crossref","first-page":"19866","DOI":"10.1074\/jbc.M000023200","volume":"275","author":"J Tang","year":"2000","unstructured":"Tang, J., Kao, P. N. & Herschman, H. R. Protein-arginine methyltransferase I, the predominant protein-arginine methyltransferase in cells, interacts with and is regulated by interleukin enhancer-binding factor 3. J. Biol. Chem. 275, 19866\u201319876 (2000).","journal-title":"J. Biol. Chem."},{"key":"134_CR15","first-page":"617919","volume":"2015","author":"DI Kim","year":"2015","unstructured":"Kim, D. I. et al. PRMT1 and PRMT4 regulate oxidative stress-induced retinal pigment epithelial cell damage in SIRT1-dependent and SIRT1-independent manners. Oxid. Med. Cell Longev. 2015, 617919 (2015).","journal-title":"Oxid. Med. Cell Longev."},{"key":"134_CR16","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1038\/sj.bjc.6604807","volume":"99","author":"K Mathioudaki","year":"2008","unstructured":"Mathioudaki, K. et al. The PRMT1 gene expression pattern in colon cancer. Br. J. Cancer 99, 2094\u20132099 (2008).","journal-title":"Br. J. Cancer"},{"key":"134_CR17","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.jhep.2014.06.032","volume":"61","author":"MJ Park","year":"2014","unstructured":"Park, M. J. et al. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1alpha regulation in vitro and in vivo. J. Hepatol. 61, 1151\u20131157 (2014).","journal-title":"J. Hepatol."},{"key":"134_CR18","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev.nutr.26.061505.111320","volume":"26","author":"MP Siroen","year":"2006","unstructured":"Siroen, M. P. et al. The clinical significance of asymmetric dimethylarginine. Annu. Rev. Nutr. 26, 203\u2013228 (2006).","journal-title":"Annu. Rev. Nutr."},{"issue":"Suppl 1","key":"134_CR19","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1177\/1358836X0501000106","volume":"10","author":"K Sydow","year":"2005","unstructured":"Sydow, K., Mondon, C. E. & Cooke, J. P. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc. Med. 10(Suppl 1), S35\u2013S43 (2005).","journal-title":"Vasc. Med."},{"key":"134_CR20","first-page":"224","volume":"52","author":"R Lu","year":"2002","unstructured":"Lu, R., Hu, C. P., Wu, X. P., Liao, E. Y. & Li, Y. J. Effect of age on bone mineral density and the serum concentration of endogenous nitric oxide synthase inhibitors in rats. Comp. Med. 52, 224\u2013228 (2002).","journal-title":"Comp. Med."},{"key":"134_CR21","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1161\/01.CIR.0000091083.61609.DF","volume":"108","author":"DP Holden","year":"2003","unstructured":"Holden, D. P., Cartwright, J. E., Nussey, S. S. & Whitley, G. S. Estrogen stimulates dimethylarginine dimethylaminohydrolase activity and the metabolism of asymmetric dimethylarginine. Circulation 108, 1575\u20131580 (2003).","journal-title":"Circulation"},{"key":"134_CR22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.jbspin.2010.05.009","volume":"78","author":"A Kemeny-Beke","year":"2011","unstructured":"Kemeny-Beke, A. et al. Increased production of asymmetric dimethylarginine (ADMA) in ankylosing spondylitis: association with other clinical and laboratory parameters. Jt. Bone Spine 78, 184\u2013187 (2011).","journal-title":"Jt. Bone Spine"},{"key":"134_CR23","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.abb.2015.11.030","volume":"590","author":"Y Morales","year":"2016","unstructured":"Morales, Y., Caceres, T., May, K. & Hevel, J. M. Biochemistry and regulation of the protein arginine methyltransferases (PRMTs). Arch. Biochem. Biophys. 590, 138\u2013152 (2016).","journal-title":"Arch. Biochem. Biophys."},{"key":"134_CR24","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cellsig.2017.03.004","volume":"34","author":"Y Dong","year":"2017","unstructured":"Dong, Y. et al. Inhibition of PRMT5 suppresses osteoclast differentiation and partially protects against ovariectomy-induced bone loss through downregulation of CXCL10 and RSAD2. Cell Signal. 34, 55\u201365 (2017).","journal-title":"Cell Signal."},{"key":"134_CR25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/sj.clpt.6100450","volume":"83","author":"SA Stoch","year":"2008","unstructured":"Stoch, S. A. & Wagner, J. A. Cathepsin K inhibitors: a novel target for osteoporosis therapy. Clin. Pharmacol. Ther. 83, 172\u2013176 (2008).","journal-title":"Clin. Pharmacol. Ther."},{"key":"134_CR26","first-page":"2088","volume":"118","author":"S Vaira","year":"2008","unstructured":"Vaira, S. et al. RelA\/p65 promotes osteoclast differentiation by blocking a RANKL-induced apoptotic JNK pathway in mice. J. Clin. Invest. 118, 2088\u20132097 (2008).","journal-title":"J. Clin. Invest."},{"key":"134_CR27","doi-asserted-by":"crossref","first-page":"3451","DOI":"10.3892\/mmr.2015.3204","volume":"11","author":"X Wang","year":"2015","unstructured":"Wang, X. et al. Amiloride inhibits osteoclastogenesis by suppressing nuclear factor-kappaB and mitogen-activated protein kinase activity in receptor activator of nuclear factor-kappaB-induced RAW 264.7 cells. Mol. Med. Rep. 11, 3451\u20133456 (2015).","journal-title":"Mol. Med. Rep."},{"key":"134_CR28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jmb.2008.01.044","volume":"377","author":"PO Hassa","year":"2008","unstructured":"Hassa, P. O., Covic, M., Bedford, M. T. & Hottiger, M. O. Protein arginine methyltransferase 1 coactivates NF-kappaB-dependent gene expression synergistically with CARM1 and PARP1. J. Mol. Biol. 377, 668\u2013678 (2008).","journal-title":"J. Mol. Biol."},{"key":"134_CR29","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3803\/EnM.2015.30.1.35","volume":"30","author":"BF Boyce","year":"2015","unstructured":"Boyce, B. F., Xiu, Y., Li, J., Xing, L. & Yao, Z. NF-kappaB-mediated regulation of osteoclastogenesis. Endocrinol. Metab. (Seoul) 30, 35\u201344 (2015).","journal-title":"Endocrinol. Metab. (Seoul)"},{"key":"134_CR30","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.yexcr.2009.01.014","volume":"315","author":"LJ Robinson","year":"2009","unstructured":"Robinson, L. J. et al. Estrogen inhibits RANKL-stimulated osteoclastic differentiation of human monocytes through estrogen and RANKL-regulated interaction of estrogen receptor-alpha with BCAR1 and Traf6. Exp. Cell Res. 315, 1287\u20131301 (2009).","journal-title":"Exp. Cell Res."},{"key":"134_CR31","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2265.2010.03828.x","volume":"73","author":"I Kanazawa","year":"2010","unstructured":"Kanazawa, I. et al. Relationships between dimethylarginine and the presence of vertebral fractures in type 2 diabetes mellitus. Clin. Endocrinol. (Oxf.) 73, 463\u2013468 (2010).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"134_CR32","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","volume":"11","author":"G Franzoso","year":"1997","unstructured":"Franzoso, G. et al. Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev. 11, 3482\u20133496 (1997).","journal-title":"Genes Dev."},{"key":"134_CR33","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1093\/ndt\/gfn716","volume":"24","author":"K Hanai","year":"2009","unstructured":"Hanai, K. et al. Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes. Nephrol. Dial. Transplant. 24, 1884\u20131888 (2009).","journal-title":"Nephrol. Dial. Transplant."},{"key":"134_CR34","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/cbin.10602","volume":"40","author":"MJ Park","year":"2016","unstructured":"Park, M. J., Oh, K. S., Nho, J. H., Kim, G. Y. & Kim, D. I. Asymmetric dimethylarginine (ADMA) treatment induces apoptosis in cultured rat mesangial cells via endoplasmic reticulum stress activation. Cell Biol. Int. 40, 662\u2013670 (2016).","journal-title":"Cell Biol. Int."},{"key":"134_CR35","doi-asserted-by":"crossref","first-page":"38005","DOI":"10.1074\/jbc.M502458200","volume":"280","author":"F Herrmann","year":"2005","unstructured":"Herrmann, F., Lee, J., Bedford, M. T. & Fackelmayer, F. O. Dynamics of human protein arginine methyltransferase 1(PRMT1) in vivo. J. Biol. Chem. 280, 38005\u201338010 (2005).","journal-title":"J. Biol. Chem."},{"key":"134_CR36","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1242\/jcs.039933","volume":"122","author":"F Herrmann","year":"2009","unstructured":"Herrmann, F., Pably, P., Eckerich, C., Bedford, M. T. & Fackelmayer, F. O. Human protein arginine methyltransferases in vivo--distinct properties of eight canonical members of the PRMT family. J. Cell Sci. 122, 667\u2013677 (2009).","journal-title":"J. Cell Sci."},{"key":"134_CR37","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3390\/ijms18071421","volume":"18","author":"MJ Park","year":"2017","unstructured":"Park, M. J., Han, H. J. & Kim, D. I. Lipotoxicity-induced PRMT1 exacerbates mesangial cell apoptosis via endoplasmic reticulum stress. Int J. Mol. Sci. 18, 1421\u20131430 (2017).","journal-title":"Int J. Mol. Sci."},{"key":"134_CR38","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1126\/science.1060781","volume":"293","author":"H Wang","year":"2001","unstructured":"Wang, H. et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 293, 853\u2013857 (2001).","journal-title":"Science"},{"key":"134_CR39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2008.10.146","volume":"378","author":"NS Soysa","year":"2009","unstructured":"Soysa, N. S. & Alles, N. NF-kappaB functions in osteoclasts. Biochem. Biophy. Res. Commun. 378, 1\u20135 (2009).","journal-title":"Biochem. Biophy. Res. Commun."},{"key":"134_CR40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1084\/jem.20051150","volume":"202","author":"M Asagiri","year":"2005","unstructured":"Asagiri, M. et al. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202, 1261\u20131269 (2005).","journal-title":"J. Exp. Med."},{"key":"134_CR41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S. & Lacey, D. L. Osteoclast differentiation and activation. Nature 423, 337\u2013342 (2003).","journal-title":"Nature"},{"key":"134_CR42","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi, H. et al. Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889\u2013901 (2002).","journal-title":"Dev. Cell"},{"key":"134_CR43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1172\/JCI200419657","volume":"114","author":"F Ikeda","year":"2004","unstructured":"Ikeda, F. et al. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. J. Clin. Invest. 114, 475\u2013484 (2004).","journal-title":"J. Clin. Invest."},{"key":"134_CR44","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","volume":"305","author":"ZH Lee","year":"2003","unstructured":"Lee, Z. H. & Kim, H. H. Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts. Biochem. Biophys. Res. Commun. 305, 211\u2013214 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"134_CR45","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0014-5793(00)02231-6","volume":"486","author":"M Matsumoto","year":"2000","unstructured":"Matsumoto, M., Sudo, T., Maruyama, M., Osada, H. & Tsujimoto, M. Activation of p38 mitogen-activated protein kinase is crucial in osteoclastogenesis induced by tumor necrosis factor. FEBS Lett. 486, 23\u201328 (2000).","journal-title":"FEBS Lett."},{"key":"134_CR46","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1083\/jcb.148.2.333","volume":"148","author":"T Miyazaki","year":"2000","unstructured":"Miyazaki, T. et al. Reciprocal role of ERK and NF-kappaB pathways in survival and activation of osteoclasts. J. Cell Biol. 148, 333\u2013342 (2000).","journal-title":"J. Cell Biol."},{"key":"134_CR47","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.bbrc.2013.09.136","volume":"440","author":"SK Lim","year":"2013","unstructured":"Lim, S. K. et al. Activation of PRMT1 and PRMT5 mediates hypoxia- and ischemia-induced apoptosis in human lung epithelial cells and the lung of miniature pigs: the role of p38 and JNK mitogen-activated protein kinases. Biochem. Biophys. Res. Commun. 440, 707\u2013713 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"134_CR48","first-page":"F85","volume":"1333","author":"A Minden","year":"1997","unstructured":"Minden, A. & Karin, M. Regulation and function of the JNK subgroup of MAP kinases. Biochim. Biophys. Acta 1333, F85\u2013F104 (1997).","journal-title":"Biochim. Biophys. Acta"},{"key":"134_CR49","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1126\/science.7939685","volume":"266","author":"AE Grigoriadis","year":"1994","unstructured":"Grigoriadis, A. E. et al. c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling. Science 266, 443\u2013448 (1994).","journal-title":"Science"},{"key":"134_CR50","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1172\/JCI11468","volume":"106","author":"BL Riggs","year":"2000","unstructured":"Riggs, B. L. The mechanisms of estrogen regulation of bone resorption. J. Clin. Invest. 106, 1203\u20131204 (2000).","journal-title":"J. Clin. Invest."},{"key":"134_CR51","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1002\/hep.25809","volume":"56","author":"D Choi","year":"2012","unstructured":"Choi, D. et al. Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner. Hepatology 56, 1546\u20131556 (2012).","journal-title":"Hepatology"},{"key":"134_CR52","doi-asserted-by":"crossref","first-page":"8836","DOI":"10.1074\/jbc.M010764200","volume":"276","author":"S Srivastava","year":"2001","unstructured":"Srivastava, S. et al. Estrogen decreases osteoclast formation by down-regulating receptor activator of NF-kappa B ligand (RANKL)-induced JNK activation. J. Biol. Chem. 276, 8836\u20138840 (2001).","journal-title":"J. Biol. Chem."},{"key":"134_CR53","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1034\/j.1600-0412.1998.770805.x","volume":"77","author":"A Pettersson","year":"1998","unstructured":"Pettersson, A., Hedner, T. & Milsom, I. Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet. Gynecol. Scand. 77, 808\u2013813 (1998).","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"134_CR54","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1365-2362.2005.01561.x","volume":"35","author":"F Schulze","year":"2005","unstructured":"Schulze, F. et al. Determination of a reference value for N(G), N(G)-dimethyl-L-arginine in 500 subjects. Eur. J. Clin. Invest. 35, 622\u2013626 (2005).","journal-title":"Eur. J. Clin. Invest."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0134-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0134-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s12276-018-0134-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T13:16:10Z","timestamp":1720530970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-018-0134-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["134"],"URL":"https:\/\/doi.org\/10.1038\/s12276-018-0134-x","relation":{},"ISSN":["1226-3613","2092-6413"],"issn-type":[{"value":"1226-3613","type":"print"},{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"3 January 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}